These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8241509)
1. Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20. Roulston D; Espinosa R; Stoffel M; Bell GI; Le Beau MM Blood; 1993 Dec; 82(11):3424-9. PubMed ID: 8241509 [TBL] [Abstract][Full Text] [Related]
2. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q). Wang PW; Iannantuoni K; Davis EM; Espinosa R; Stoffel M; Le Beau MM Genes Chromosomes Cancer; 1998 Feb; 21(2):75-81. PubMed ID: 9491317 [TBL] [Abstract][Full Text] [Related]
3. Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map. Wang PW; Eisenbart JD; Espinosa R; Davis EM; Larson RA; Le Beau MM Genomics; 2000 Jul; 67(1):28-39. PubMed ID: 10945467 [TBL] [Abstract][Full Text] [Related]
4. Molecular heterogeneity at the breakpoints of smaller 20q deletions. Hollings PE Genes Chromosomes Cancer; 1994 Sep; 11(1):21-8. PubMed ID: 7529043 [TBL] [Abstract][Full Text] [Related]
5. Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies. Okada M; Suto Y; Hirai M; Shiseki M; Usami A; Okajima K; Teramura M; Mori N; Motoji T Cancer Genet; 2012; 205(1-2):18-24. PubMed ID: 22429594 [TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909 [TBL] [Abstract][Full Text] [Related]
7. Double Philadelphia masquerading as chromosome 20q deletion--a new recurrent abnormality in chronic myeloid leukaemia blast crisis. Reid AG; Swanton S; Grace C; Campbell LJ; Green AR; Nacheva EP; Br J Haematol; 2003 Nov; 123(3):442-8. PubMed ID: 14617003 [TBL] [Abstract][Full Text] [Related]
8. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Zhao N; Stoffel A; Wang PW; Eisenbart JD; Espinosa R; Larson RA; Le Beau MM Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6948-53. PubMed ID: 9192672 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290 [TBL] [Abstract][Full Text] [Related]
10. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes. Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396 [TBL] [Abstract][Full Text] [Related]
11. Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes. Nacheva E; Holloway T; Carter N; Grace C; White N; Green AR Cancer Genet Cytogenet; 1995 Apr; 80(2):87-94. PubMed ID: 7736443 [TBL] [Abstract][Full Text] [Related]
12. Localization of the SRC oncogene to chromosome band 20q11.2 and loss of this gene with deletion (20q) in two leukemic patients. Morris CM; Honeybone LM; Hollings PE; Fitzgerald PH Blood; 1989 Oct; 74(5):1768-73. PubMed ID: 2506951 [TBL] [Abstract][Full Text] [Related]
13. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions. Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294 [TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome. Douet-Guilbert N; Laï JL; Basinko A; Gueganic N; Andrieux J; Pollet B; Plantier I; Delattre C; Crépin O; Corm S; Le Bris MJ; Morel F; De Braekeleer M Br J Haematol; 2008 Dec; 143(5):716-20. PubMed ID: 19036015 [TBL] [Abstract][Full Text] [Related]
15. Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines. MacGrogan D; Alvarez S; DeBlasio T; Jhanwar SC; Nimer SD Oncogene; 2001 Jul; 20(31):4150-60. PubMed ID: 11464281 [TBL] [Abstract][Full Text] [Related]
16. Delineation of multiple deleted regions in 7q in myeloid disorders. Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433 [TBL] [Abstract][Full Text] [Related]
17. Deletions of chromosome 5 in malignant myeloid disorders. Le Beau MM Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109 [TBL] [Abstract][Full Text] [Related]
18. Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells. Yin CC; Tang G; Lu G; Feng X; Keating MJ; Medeiros LJ; Abruzzo LV Mod Pathol; 2015 Aug; 28(8):1130-7. PubMed ID: 25953391 [TBL] [Abstract][Full Text] [Related]
19. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039 [TBL] [Abstract][Full Text] [Related]
20. Microarray CGH analysis of hematological patients with del(20q). Wu C; Pan J; Qiu H; Xue Y; Chen S; Wu Y; zhang J; Bai S; Wang Y; Shen J; Gong Y Int J Hematol; 2015 Nov; 102(5):617-25. PubMed ID: 26440974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]